Vaxart secures European patent for oral norovirus vaccine platform
Novo Nordisk: semaglutide clears obesity threshold in 40% of children
Novartis pelacarsen Phase III trial fails to cut CV events
Globus Medical wins CE Mark for Excelsius3D imaging system in EU and UK
Magrabi Health earns first global SRC Network of Excellence in
Newron completes ENIGMA-TRS 1 screening with 12-week data due Q1 2027
ONWARD Medical starts EIGER implant study for spinal cord injury
Tangram Therapeutics advances TGM-312 into MASH patient cohorts
Tensive gets €20m EIB loan for bioresorbable breast implant
Scribe Therapeutics IPO raises $155m as STX-1150 enters clinic
Lecanemab subcutaneous autoinjector approved in China for early AD
Teva's TEV-408 meets primary endpoint in celiac Phase 2a
Opus Genetics to unveil OPGx-BEST1 Phase 1/2 data on 9 September
AiM Medical Robotics wins $2m NCI grant for MRI brain robot
Nyxoah ACCCESS study hits safety and efficacy endpoints in CCC patients
